Improving medication risk management among residents of retirement villages

Not Applicable

Completed

• Conditions: Risk for medication misadventure; The uptake of Home Medicines Review (HMR) service; Public Health - Health service research

• Registration Number: ACTRN12611000109909
• Lead Sponsor: Monash University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-02-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Live in one of the participating retirement villages;
Use three or more prescribed medications;
Expecting to visit General Pracitioner in the next three months;
Expecting to be available for follow up for at least six
months from baseline; and
Available for education sessions offered by a consultant or HMR pharmacist.

Exclusion Criteria

Have received a Home Medicines Review (HMR) in the previous 12 months;
Planning to move from their current retirement village in the next six months;
Unable to give written informed consent; or
Unable to communicate in English.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patient self-reported uptake of Home Medicines Review (HMR) service is the primary outcome measure. This will be measured as the proportions of participants in the two groups who have had at least one HMR since baseline. Patients will be interviewed over the phone to obtain this information. The information will be verified against health profefssionals' reports (General Practitioner, community pharmacist or consultant pharmacist).[At 3 and 6 months after intervention commencement.]

Secondary Outcome Measures

Name	Time	Method
Medication adherence will be the secondary outcome measure of the study. Participants will be assessed for medication adherence using the validated 4-item Morisky scale at baseline and at 6 months. Data will be collected using participant self-administered questionnaires at baseline and interviewer-administered questionnaires via telephone at 6 months. [At baseline and at 6 months after intervention commencement.];Quality of life will be other outcome measure of the study. The Short Form (SF)-12 Health Survey, which has 12 validated items, will be used to assess participant's health and quallity of life at baseline and at 6 months. Data will be collected using participant self-administered questionnaires at baseline and interviewer-administered questionnaire via telephone at 6 months. <br>[At baseline and at 6 months after intervention commencement.]